Savara Pharmaceuticals
SVRA
#6613
Rank
NZ$0.87 B
Marketcap
$5.08
Share price
-6.58%
Change (1 day)
-16.33%
Change (1 year)

Operating Margin for Savara Pharmaceuticals (SVRA)

Operating Margin as of November 2024 (TTM): -4,818.54%

According to Savara Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -4,818.54%. At the end of 2020 the company had an Operating Margin of -19,305.45%.

Operating Margin history for Savara Pharmaceuticals from 2009 to 2020

Operating Margin at the end of each year

Year Operating Margin Change
2020-19,305.45%
2016-2,820.00%-83.08%
2015-16,664.81%
2010-1,728.35%-54.22%
2009-3,775.02%-29.17%
2008-5,329.50%20.35%
2007-4,428.41%
2005-2,661.58%
2003-18,106.67%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-8,391.15% 74.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-34.14%-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.